http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-200200712-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D221-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-153
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4741
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2002-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2003-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-200200712-A1
titleOfInvention NEW COMPOUNDS BENZO [b] PIRANO [3,2-h] ACRIDIN-7-SHE, METHOD FOR THEIR PRODUCTION AND CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS
abstract The compounds of formula (I) where X and Y denote a group selected from hydrogen, halogen, mercapto, cyano, nitro, alkyl, trihaloalkyl, trihaloalkylcarbonylamino, -ORa, -NRaRb, -NRa-C (O) -T, -OC (O ) -T, OT-NRaRb, -OT-ORa, -NRa-T-NRaRb, -NRa-T-ORa and -NRa-T-CORa, where Ra, Rb, T, T correspond to the definitions in the description, or X and Y together form methylenedioxy or ethylenedioxy, R represents a hydrogen atom or an alkyl group, R represents a group selected from hydrogen, -ORa, -NRaRb, -NRa-C (O) -T, OC (O) -T, -OT- NRaRb, -OT-ORa, -NRa-T-NRaRb, -NRa-T-ORa and NRa-T-CORa, where Ra, Rb, T and T correspond to the above divisions, R and R denote a hydrogen atom or an alkyl group, W represents a group of the formula -CH (R) -CH (R) -, -CH = C (R) -, -C (R) = CH- or C (O) - CH (R) -, where R, R, R and R correspond to the definitions given in the description, their isomers and N-oxides, as well as their additional salts with a pharmaceutically acceptable acid or base. Medications.
priorityDate 2001-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397808
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655

Total number of triples: 26.